Lines
Halgen Limited ( “Halgen”), established in the National Health Technology Park of Torch Development Zone, Zhongshan City, with a registered initial VC investment of RMB 30 million, is engaged in the R&D and manufacture of gene microarray and auxiliary biological reagents and instruments for clinical and research applications and services.
The Company owns 10 gene-microarray related patents and 1000 m2 GMP space for production of clinical gene microarrays and related products.